Oberweis Micro-Cap Fund

3333 WARRENVILLE ROAD,SUITE 500
LISLE , IL, 60532

Rank

Rank Universe

Summary

The fund seeks long-term capital appreciation by investing in micro-cap companies in the United States.

The investment process starts with a list of companies included in the benchmark index and with market capitalization less than $600 million. The research team then using systematic principles and fundamental analysis identifies a list of companies with attractive long-term earnings growth. 

Next, the team using qualitative analysis and industry research narrows the list to include companies with market leadership,

Link

Directors

Mar 14, 2024
  • Katherine Smith Dedrick
  • Alix J. Charles
  • Michael J. Simon

Chief Compliance Officer

  • Thomas P. Joyce

Fund Manager(s)

  • James Oberweis
  • Kenneth Farsalas

Price

  • $44.67 ( +0.88 ) Nov 1, 2024 Last Close
  • Net Assets
  • $451.8M
    Feb 29, 2024
    More
  • 52-Week High/Low
  • $0 - $0
  • Turnover
  • 59.2%
  • Expense Ratio
  • 1.53%

Company Name

Holding

ADMA Biologics Inc 4.46 %
American Superconductor Corp 2.9 %
ACM Research Inc 1.88 %
Artivion Inc 1.42 %
Applied Optoelectronics Inc 1.4 %
Alpha & Omega Semiconductor Lt 1.32 %
Aehr Test Systems 1.17 %
Aviat Networks Inc 1.12 %
Alphatec Holdings Inc 1.04 %
Amphastar Pharmaceuticals Inc 0.71 %
More

Documents

Prospectus

Annual Reports

Performance

YTD

2.1%

3 Year

4.56%

5 Year

107.38%

Best

108.77%

2003

Worst

-53.03%

2008

Alpha

OBMCX Russell 2000 Index

Chart +